GIST AND CML

Clinical trials for GIST AND CML explained in plain language.

Never miss a new study

Get alerted when new GIST AND CML trials appear

Sign up with your email to follow new studies for GIST AND CML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Cancer patients get chance to stay on lifesaving drug in new safety study

Disease control Ongoing

This study allows patients with gastrointestinal stromal tumors (GIST) or chronic myeloid leukemia (CML) who are already benefiting from the drug imatinib to continue receiving it. The main goal is to collect long-term safety information by monitoring patients for side effects. I…

Matched conditions: GIST AND CML

Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

GIST AND CML

Get alerted when new GIST AND CML trials appear

Cancer patients get chance to stay on lifesaving drug in new safety study